Is Brain Maturation Comparable in Fetuses and Premature Neonates at Term Equivalent Age?

References

1. 1.↵
   1. Miller SP,
   2. Vigneron DB,
   3. Henry RG,
   4. et al

   . Serial quantitative diffusion tensor MRI of the premature brain: development in newborns with and without injury. J Magn Reson Imaging 2002;16:621–32

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Huppi PS,
   2. Warfield S,
   3. Kikinis R,
   4. et al

   . Quantitative magnetic resonance imaging of brain development in premature and mature newborns. Ann Neurol 1998;43:224–35

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Schneider JF,
   2. Confort-Gouny S,
   3. Le Fur Y,
   4. et al

   . Diffusion-weighted imaging in normal fetal brain maturation. Eur Radiol 2007;17:2422–29

   CrossRefPubMed
4. 4.↵
   1. Bydder GM,
   2. Rutherford MA

   . Diffusion-weighted imaging of the brain in neonates and infants. Magn Reson Imaging Clin N Am 2001;9:83–98, viii

   PubMed
5. 5.↵
   1. Huppi PS,
   2. Murphy B,
   3. Maier SE,
   4. et al

   . Microstructural brain development after perinatal cerebral white matter injury assessed by diffusion tensor magnetic resonance imaging. Pediatrics 2001;107:455–60

   Abstract/FREE Full Text
6. 6.↵
   1. Prayer D,
   2. Barkovich AJ,
   3. Kirschner DA,
   4. et al

   . Visualization of nonstructural changes in early white matter development on diffusion-weighted MR images: evidence supporting premyelination anisotropy. AJNR Am J Neuroradiol 2001;22:1572–76

   Abstract/FREE Full Text
7. 7.↵
   1. Cecil KM

   . MR spectroscopy of metabolic disorders. Neuroimaging Clin N Am 2006;16:87–116, viii

   CrossRefPubMedWeb of Science
8. 8.↵
   1. Kreis R,
   2. Ernst T,
   3. Ross BD

   . Development of the human brain: in vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy. Magn Reson Med 1993;30:424–37

   CrossRefPubMedWeb of Science
9. 9.↵
   1. Brighina E,
   2. Bresolin N,
   3. Pardi G,
   4. et al

   . Human fetal brain chemistry as detected by proton magnetic resonance spectroscopy. Pediatr Neurol 2009;40:327–42

   CrossRefPubMed
10. 10.↵
    1. Kreis R,
    2. Hofmann L,
    3. Kuhlmann B,
    4. et al

    . Brain metabolite composition during early human brain development as measured by quantitative in vivo 1H magnetic resonance spectroscopy. Magn Reson Med 2002 48:949–58

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Heerschap A,
    2. van den Berg PP

    . Proton magnetic resonance spectroscopy of human fetal brain. Am J Obstet Gynecol 1994;170:1150–51

    PubMed
12. 12.↵
    1. Girard N,
    2. Gouny SC,
    3. Viola A,
    4. et al

    . Assessment of normal fetal brain maturation in utero by proton magnetic resonance spectroscopy. Magn Reson Med 2006;56:768–75

    CrossRefPubMed
13. 13.↵
    1. Girard N,
    2. Fogliarini C,
    3. Viola A,
    4. et al

    . MRS of normal and impaired fetal brain development. Eur J Radiol 2006;57:217–25

    CrossRefPubMed
14. 14.↵
    1. Kok RD,
    2. van den Berg PP,
    3. van den Bergh AJ,
    4. et al

    . Maturation of the human fetal brain as observed by 1H MR spectroscopy. Magn Reson Med 2002;48:611–16

    CrossRefPubMedWeb of Science
15. 15.↵
    1. Kok RD,
    2. van den Bergh AJ,
    3. Heerschap A,
    4. et al

    . Metabolic information from the human fetal brain obtained with proton magnetic resonance spectroscopy. Am J Obstet Gynecol 2001;185:1011–15

    CrossRefPubMed
16. 16.↵
    1. Cady EB,
    2. Penrice J,
    3. Amess PN,
    4. et al

    . Lactate, N-acetylaspartate, choline and creatine concentrations, and spin-spin relaxation in thalamic and occipito-parietal regions of developing human brain. Magn Reson Med 1996;36:878–86

    CrossRefPubMed
17. 17.↵
    1. Vanhamme L,
    2. van den Boogaart A,
    3. Van Huffel S

    . Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson 1997;129:35–43

    CrossRefPubMedWeb of Science
18. 18.↵
    1. Gimenez M,
    2. Miranda MJ,
    3. Born AP,
    4. et al

    . Accelerated cerebral white matter development in preterm infants: a voxel-based morphometry study with diffusion tensor MR imaging. Neuroimage 2008;1 41:728–34
19. 19.↵
    1. Morriss MC,
    2. Zimmerman RA,
    3. Bilaniuk LT,
    4. et al

    . Changes in brain water diffusion during childhood. Neuroradiology 1999;41:929–34

    CrossRefPubMedWeb of Science
20. 20.↵
    1. Neil JJ,
    2. Shiran SI,
    3. McKinstry RC,
    4. et al

    . Normal brain in human newborns: apparent diffusion coefficient and diffusion anisotropy measured by using diffusion tensor MR imaging. Radiology 1998;209:57–66

    PubMedWeb of Science
21. 21.↵
    1. Prayer D,
    2. Prayer L

    . Diffusion-weighted magnetic resonance imaging of cerebral white matter development. Eur J Radiol 2003;45:235–43

    CrossRefPubMedWeb of Science
22. 22.↵
    1. Dudink J,
    2. Kerr JL,
    3. Paterson K,
    4. et al

    . Connecting the developing preterm brain. Early Hum Dev 2008;84:777–82

    CrossRefPubMedWeb of Science
23. 23.↵
    1. Mukherjee P,
    2. Miller JH,
    3. Shimony JS,
    4. et al

    . Normal brain maturation during childhood: developmental trends characterized with diffusion-tensor MR imaging. Radiology 2001;221:349–58

    CrossRefPubMedWeb of Science
24. 24.↵
    1. Tanner SF,
    2. Ramenghi LA,
    3. Ridgway JP,
    4. et al

    . Quantitative comparison of intrabrain diffusion in adults and preterm and term neonates and infants. AJR Am J Roentgenol 2000;174:1643–49

    PubMedWeb of Science
25. 25.↵
    1. Wimberger DM,
    2. Roberts TP,
    3. Barkovich AJ,
    4. et al

    . Identification of “premyelination” by diffusion-weighted MRI. J Comput Assist Tomogr 1995;19:28–33

    PubMedWeb of Science
26. 26.↵
    1. Back SA,
    2. Luo NL,
    3. Borenstein NS,
    4. et al

    . Arrested oligodendrocyte lineage progression during human cerebral white matter development: dissociation between the timing of progenitor differentiation and myelinogenesis. J Neuropathol Exp Neurol 2002;61:197–211

    PubMedWeb of Science
27. 27.↵
    1. Neil J,
    2. Miller J,
    3. Mukherjee P,
    4. et al

    . Diffusion tensor imaging of normal and injured developing human brain—a technical review. NMR Biomed 2002;15:543–52

    CrossRefPubMedWeb of Science
28. 28.↵
    1. Hagen T,
    2. Ahlhelm F,
    3. Reiche W

    . Apparent diffusion coefficient in vasogenic edema and reactive astrogliosis. Neuroradiology 2007;49:921–26

    CrossRefPubMed
29. 29.↵
    1. Back SA,
    2. Luo NL,
    3. Borenstein NS,
    4. et al

    . Late oligodendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury. J Neurosci 2001;21:1302–12

    Abstract/FREE Full Text
30. 30.↵
    1. Rose SE,
    2. Hatzigeorgiou X,
    3. Strudwick MW,
    4. et al

    . Altered white matter diffusion anisotropy in normal and preterm infants at term-equivalent age. Magn Reson Med 2008;60:761–67

    CrossRefPubMed
31. 31.↵
    1. Lopez-Beltran EA,
    2. Mate MJ,
    3. Cerdan S

    . Dynamics and environment of mitochondrial water as detected by 1H NMR. J Biol Chem 1996;271:10648–53

    Abstract/FREE Full Text
32. 32.↵
    1. Murphy PS,
    2. Leach MO,
    3. Rowland IJ

    . Signal modulation in (1)H magnetic resonance spectroscopy using contrast agents: proton relaxivities of choline, creatine, and N-acetylaspartate. Magn Reson Med 1999;42:1155–58

    CrossRefPubMed
33. 33.↵
    1. Erecinska M,
    2. Cherian S,
    3. Silver IA

    . Energy metabolism in mammalian brain during development. Prog Neurobiol 2004;73:397–445

    CrossRefPubMedWeb of Science
34. 34.↵
    1. Larvaron P,
    2. Bielicki G,
    3. Boespflug-Tanguy O,
    4. et al

    . Proton MRS of early post-natal mouse brain modifications in vivo. NMR Biomed 2006;19:180–87

    CrossRefPubMedWeb of Science
35. 35.↵
    1. Helms G,
    2. Frahm J

    . Magnetization transfer attenuation of creatine resonances in localized proton MRS of human brain in vivo. NMR Biomed 1999;12:490–94

    CrossRefPubMed
36. 36.↵
    1. Luo Y,
    2. Rydzewski J,
    3. de Graaf RA,
    4. et al

    . In vivo observation of lactate methyl proton magnetization transfer in rat C6 glioma. Magn Reson Med 1999;41:676–85

    CrossRefPubMed
37. 37.↵
    1. Huppi PS,
    2. Posse S,
    3. Lazeyras F,
    4. et al

    . Magnetic resonance in preterm and term newborns: 1H-spectroscopy in developing human brain. Pediatr Res 1991;30:574–78

    PubMedWeb of Science
38. 38.↵
    1. Moffett JR,
    2. Ross B,
    3. Arun P,
    4. et al

    . N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology. Prog Neurobiol 2007;81:89–131

    CrossRefPubMedWeb of Science
39. 39.↵
    1. Chakraborty G,
    2. Mekala P,
    3. Yahya D,
    4. et al

    . Intraneuronal N-acetylaspartate supplies acetyl groups for myelin lipid synthesis: evidence for myelin-associated aspartoacylase. J Neurochem 2001;78:736–45

    CrossRefPubMedWeb of Science
40. 40.↵
    1. Urenjak J,
    2. Williams SR,
    3. Gadian DG,
    4. et al

    . Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 1993;13:981–89

    Abstract
41. 41.↵
    1. Bhakoo KK,
    2. Pearce D

    . In vitro expression of N-acetyl aspartate by oligodendrocytes: implications for proton magnetic resonance spectroscopy signal in vivo. J Neurochem 2000;74:254–62

    CrossRefPubMedWeb of Science
42. 42.↵
    1. Bak LK,
    2. Schousboe A,
    3. Waagepetersen HS

    . The glutamate/GABA-glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer. J Neurochem 2006;98:641–53

    CrossRefPubMedWeb of Science
43. 43.↵
    1. Gallo V,
    2. Zhou JM,
    3. McBain CJ,
    4. et al

    . Oligodendrocyte progenitor cell proliferation and lineage progression are regulated by glutamate receptor-mediated K+ channel block. J Neurosci 1996;16:2659–70

    Abstract/FREE Full Text
44. 44.↵
    1. Brand A,
    2. Richter-Landsberg C,
    3. Leibfritz D

    . Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev Neurosci 1993;15:289–98

    CrossRefPubMedWeb of Science
45. 45.↵
    1. Boulanger Y,
    2. Labelle M,
    3. Khiat A

    . Role of phospholipase A(2) on the variations of the choline signal intensity observed by 1H magnetic resonance spectroscopy in brain diseases. Brain Res Brain Res Rev 2000;33:380–89

    CrossRefPubMed
46. 46.↵
    1. Farooqui AA,
    2. Horrocks LA,
    3. Farooqui T

    . Glycerophospholipids in brain: their metabolism, incorporation into membranes, functions, and involvement in neurological disorders. Chem Phys Lipids 2000;106:1–29

    CrossRefPubMedWeb of Science
47. 47.↵
    1. Klein J

    . Membrane breakdown in acute and chronic neurodegeneration: focus on choline-containing phospholipids. J Neural Transm 2000;107:1027–63

    CrossRefPubMedWeb of Science